PYC TherapeuticsPYCXF

13F holders, Q3 2024 (September 30)
1holders
$0.12avg. 13F price*

At the end of Q3 2024, 1 institutions reported holding PYC Therapeutics Ltd. (PYCXF) in their 13F filings. The largest holder was Eagle Bay Advisors LLC ($5K).

Company
PYC Therapeutics Ltd.
CUSIP
Q77904128
Latest filing quarter
Q3 2024

Total Exit/New Position Q3 2024

InstitutionsTotal Value
New Positions1$5K
Exits0$0

Ownership 1 holders

Eagle Bay Advisors LLC 0.00% New 40,000 $5K

"% of holder's portfolio" is PYCXF's weight in each manager's 13F, not the share of PYC Therapeutics Ltd. the manager owns.